Metabolic Acidosis Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition.
DelveInsight’s “Metabolic Acidosis Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of the Metabolic Acidosis, historical and forecasted epidemiology as well as the Metabolic Acidosis market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Discover Key Insights into the Metabolic Acidosis Market with DelveInsight’s In-Depth Report @ Metabolic Acidosis Market Size
Key Takeaways from the Metabolic Acidosis Market Report
- In November 2024:- Tisento Therapeutics- The PRIZM study is evaluating 2 dose levels of zagociguat in a crossover design consisting of two 12-week treatment periods separated by a 4-week washout. Patients will be screened and if eligible, randomly assigned either to receive placebo in period 1 followed by active drug in period 2 OR to receive active drug in period 1 followed by placebo in period 2.
- In 2023, approximately 1.7 million prevalent cases of metabolic acidosis were diagnosed across the seven major markets (7MM). Of these, around 850,000 cases in the United States were linked to metabolic acidosis in patients with chronic kidney disease (CKD) stages 3 to 5, while the remaining cases were associated with diagnosed cases of distal renal tubular acidosis (dRTA), both inherited and acquired.
- A significant number of metabolic acidosis cases were observed in males, accounting for approximately 55% of the total cases. This higher prevalence in males is due to a greater incidence of underlying conditions such as chronic kidney disease and diabetes, which are more common in men and are major contributors to the development of metabolic acidosis.
- In 2023, treated cases of distal renal tubular acidosis (dRTA), both inherited and acquired, represented less than 1.5% of all treated metabolic acidosis cases in the United States. This is attributed to the relative rarity of dRTA as a cause of metabolic acidosis, especially when compared to more prevalent conditions such as diabetic ketoacidosis and lactic acidosis.
- The leading Metabolic Acidosis Companies such as Tricida, Advicenne Pharma, Thiogenesis Therapeutics, Inc., Tisento Therapeutics, ModernaTX, and others.
- Promising Metabolic Acidosis Therapies such as TTI-0102, Zagociguat 15mg, mRNA-3705, Sonlicromanol, and others.
Stay ahead in the Metabolic Acidosis Therapeutics Market with DelveInsight’s Strategic Report @ Metabolic Acidosis Market Outlook
Metabolic Acidosis Epidemiology Segmentation in the 7MM
- Total Prevalence of Chronic Kidney Disorder Patients
- Total Prevalence of Metabolic Acidosis in Chronic Kidney Disorder Patients
- Total Prevalent Cases of Metabolic Acidosis
- Total Prevalent Population of Distal Renal Tubular Acidosis
- Total Diagnosed Population
- Gender-specific diagnosed cases
Download the report to understand which factors are driving Metabolic Acidosis epidemiology trends @ Metabolic Acidosis Prevalence
Metabolic Acidosis Emerging Drugs
Zagociguat: Tisento Therapeutics
Zagociguat is an investigational medicine that is taken as a once-a-day oral tablet. Zagociguat has been studied in 5 clinical trials, including a Phase IIa trial in participants with MELAS. It acts as a potent stimulator of sGC, enhancing the production of cyclic GMP (cGMP) in response to nitric oxide. This pathway plays a crucial role in regulating vascular tone and reducing inflammation.
Metabolic Acidosis Market Outlook
The metabolic acidosis market presents a diverse landscape across the major global markets, reflecting varying levels of demand and healthcare infrastructure. In 2023, the market for metabolic acidosis therapies exhibited significant disparities in size and growth potential among the seven major markets (7MM). In 2023, The United States emerged as the largest market by far, capturing approximately USD 117.6 million, while Europe, including Germany, France, Italy, Spain, and the UK, showcased a range of market sizes.
Get In-Depth Knowledge on Metabolic Acidosis Market Trends and Forecasts with DelveInsight @ Metabolic Acidosis Treatment Market
Scope of the Metabolic Acidosis Market Report
- Coverage- 7MM
- Metabolic Acidosis Companies- Tricida, Advicenne Pharma, Thiogenesis Therapeutics, Inc., Tisento Therapeutics, ModernaTX, and others.
- Metabolic Acidosis Therapies- TTI-0102, Zagociguat 15mg, mRNA-3705, Sonlicromanol, and others..
- Metabolic Acidosis Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
- Metabolic Acidosis Unmet Needs, KOL’s views, Analyst’s views, Metabolic Acidosis Market Access and Reimbursement
Unlock Strategic Insights with DelveInsight’s Comprehensive Metabolic Acidosis Market Report @ Metabolic Acidosis Market Drivers and Barriers
Table of Content
1. Key Insights
2. Report Introduction
3. Metabolic Acidosis Market Overview at a Glance
4. Methodology
5. Executive Summary
6. Disease Background and Overview
7. Diagnosis
8. Treatment of metabolic acidosis
9. Diagnostic and Treatment Guidelines for Metabolic Acidosis
10. Conclusion
11. Epidemiology and Patient Population
12. Patient Journey
13. Emerging Therapies
14. Market Analysis
15. KOL Views
16. Market Barriers
17. Market Drivers
18. SWOT Analysis
19. Unmet Needs
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: Metabolic Acidosis Market Size is estimated to grow with a significant CAGR by 2034, estimates DelveInsight